BUILDING THE FUTURE OF CKD THERAPY THROUGH MECHANISM‑DRIVEN DELIVERY PLATFORMS, HUMAN‑GENETIC PATHWAYS, & EARLY INDICATORS OF TREATMENT RESPONSE